Citation Impact
Citing Papers
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
2006 Standout
Prospective identification of tumorigenic breast cancer cells
2003 Standout
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Facts and Controversies in Systemic Treatment of Metastatic Breast Cancer
2004
The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials
2001 Standout
Breast cancer
2019 Standout
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Comparison of anastrozole versus tamoxifen as preoperative therapy in postmenopausal women with hormone receptor‐positive breast cancer
2006
Emerging roles of PKM2 in cell metabolism and cancer progression
2012 StandoutNobel
Tamoxifen in advanced breast cancer
1978
Plasma levels of the atherogenic amino acid homocysteine in postmenopausal women with breast cancer treated with tamoxifen
1995
Systematic reviews of chemotherapy and endocrine therapy in metastatic breast cancer
2000
The third dimension bridges the gap between cell culture and live tissue
2007 Standout
Intravenous naftidrofuryl for critical limb ischaemia
2000
Breast cancer
2016 Standout
Stem cells, cancer, and cancer stem cells
2001 StandoutNature
Role of Transforming Growth Factor β in Human Disease
2000 Standout
Epidermal growth factor-related peptides and their receptors in human malignancies
1995 Standout
Ovarian cancer
2014 Standout
Dietary Intake and Bioavailability of Polyphenols
2000 Standout
Taking advantage of luminescent lanthanide ions
2005 Standout
Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women
1994
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
2007 Standout
Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 women.
1998
Estrogen Receptor Breast Cancer Phenotypes in the Surveillance, Epidemiology, and End Results Database
2002
The benefits and harms of breast cancer screening: an independent review
2013
Legumes and soybeans: overview of their nutritional profiles and health effects
1999 Standout
The emergence of gender differences in depression during adolescence.
1994 Standout
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
2004 Standout
Biological effects of isoflavones in young women: importance of the chemical composition of soyabean products
1995
The development of androgen-independent prostate cancer
2001 Standout
A woman's heart
2009
The value of aspiration cytologic examination of the breast a statistical review of the medical literature
1992
Serum Tumor Markers in Breast Cancer: Are They of Clinical Value?
2006
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Tamoxifen in the Treatment of Breast Cancer
1988
Using Raman spectroscopy to characterize biological materials
2016 Standout
Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
1998 Standout
Recent Advances in the Treatment of Breast Cancer
1991
Epidermal growth factor receptor (EGFr) status associated with failure of primary endocrine therapy in elderly postmenopausal patients with breast cancer
1988
A prospective randomized controlled trial of tumour chemosensitivity assay directed chemotherapy versus physician's choice in patients with recurrent platinum-resistant ovarian cancer
2007
Cardiac and vascular morbidity in women receiving adjuvant tamoxifen for breast cancer in a randomised trial
1995
Polyphenols: food sources and bioavailability
2004 Standout
Liquid biopsies come of age: towards implementation of circulating tumour DNA
2017 Standout
Measuring quality of life in cancer patients.
1989
Tamoxifen in the Treatment of Breast Cancer
1998
Care of the Cancer Survivor: Metabolic Syndrome after Hormone-Modifying Therapy
2009
Advances in estrogen receptor biology: prospects for improvements in targeted breast cancer therapy
2003
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
2004 Standout
Silencing of pkm2 increases the efficacy of docetaxel in human lung cancer xenografts in mice
2010
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2019 Standout
Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: results of a prospective Southwest Oncology Group study.
1992
Coronary Heart Disease Mortality and Adjuvant Tamoxifen Therapy
1997
Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
2001 Standout
Meta-Analysis of the Effects of Soy Protein Intake on Serum Lipids
1995 Standout
Non-specific low back pain
2011 Standout
The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.
1993 Standout
The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress
1994 Standout
Atherosclerosis
2001 Standout
Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: Recommendations of the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009)
2010
Levels of TGF-α and EGFR Protein in Head and Neck Squamous Cell Carcinoma and Patient Survival
1998 Standout
Endogenous Steroid Hormone Concentrations and Risk of Breast Cancer Among Premenopausal Women
2006 Standout
Prognostic role of serum CA15.3 in 362 node-negative breast cancers. An old player for a new game
2002
The clinical value of CEA and CA 15-3 in breast cancer management
1995
Estrogen and progesterone receptors in the normal female breast.
1991
The pharmacology and clinical uses of tamoxifen
1984
Luminescent Lanthanide Chelate Contrast Agents and Detection of Lesions in the Hamster Oral Cancer Model
2003
Cancer Therapy–Induced Cardiac Toxicity in Early Breast Cancer
2012
Tamoxifen Decreases Cholesterol Sevenfold and Abolishes Lipid Lesion Development in Apolipoprotein E Knockout Mice
1997
Male reproductive health and environmental xenoestrogens.
1996 Standout
STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration
2016 Standout
Breast Cancer Statistics, 2022
2022 Standout
Premenstrual syndromes: overview from a methodologic perspective
1984
Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement
2016 Standout
Protective actions of tamoxifen and 4-hydroxytamoxifen against oxidative damage to human low-density lipoproteins: a mechanism accounting for the cardioprotective action of tamoxifen?
1993
Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A
1986 StandoutNature
Advanced Transmission Raman Spectroscopy: A Promising Tool for Breast Disease Diagnosis
2008
Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy
1992 Standout
Mechanisms of Estrogen Action
2001 Standout
Hormonal Chemoprevention of Cancer in Women
1993 Science
Sex differences in unipolar depression: Evidence and theory.
1987 Standout
Intravenous naftidrofuryl for critical limb ischaemia
2012
The Effects of Plant Flavonoids on Mammalian Cells:Implications for Inflammation, Heart Disease, and Cancer
2000 Standout
Estrogen and progesterone receptor proteins in breast cancer
1979
Combined Tamoxifen and Luteinizing Hormone-Releasing Hormone (LHRH) Agonist Versus LHRH Agonist Alone in Premenopausal Advanced Breast Cancer: A Meta-Analysis of Four Randomized Trials
2001
Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma
1999 Standout
Serum CA 15.3, CEA and ESR Patterns in Breast Cancer
1997
Homocysteine and Cardiovascular Disease
1998 Standout
Tamoxifen for early breast cancer: an overview of the randomised trials
1998 Standout
The Use of 3-D Cultures for High-Throughput Screening: The Multicellular Spheroid Model
2004
Selective Estrogen Receptor Modulators: Clinical Spectrum*
1999
A Transmembrane Intracellular Estrogen Receptor Mediates Rapid Cell Signaling
2005 StandoutScience
Effect of Short-Term Hormone Replacement Therapy on Breast Cancer Risk Reduction After Bilateral Prophylactic Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group
2005 Standout
Prognostic value of pre-operative serum CA 15.3 levels in breast cancer.
2006
Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer
1996 Standout
Works of P E Preece being referenced
Needle aspiration of the breast with immediate reporting of material.
1979
Correlation of the clinical response to chemotherapy in breast cancer with ex vivo chemosensitivity
1996
Long term effects of tamoxifen on blood lipid values in breast cancer.
1992
Efficacy of Early Diagnosis and Treatment in Women with a Family History of Breast Cancer
1999
A controlled study of the ocular effects of tamoxifen in conventional dosage in the treatment of breast carcinoma
1989
Heterogeneity of chemosensitivity in human breast carcinoma: use of an adenosine triphosphate (ATP) chemiluminescence assay.
1993
A double blind trial of the prolactin inhibitor bromocriptine in painful benign breast disease
1978
Tamoxifen as initial sole treatment of localised breast cancer in elderly women: a pilot study.
1982
Proceedings: Hormones in breast cancer patients on tamoxifen
1975
Is mammographic microcalcification of biological significance?
1993
A randomized comparison of tamoxifen with surgical oophorectomy in premenopausal patients with advanced breast cancer.
1986
A pilot study of radical radiotherapy using a perioperative implant following wide local excision for carcinoma of the breast
1999
Plasma hormones in patients with advanced breast cancer treated with tamoxifen
1976
Potential use of tumour marker CA 15-3 in the staging and prognosis of patients with breast cancer.
1991
The Usefulness of Naftidrofuryl in Severe Peripheral Ischaemia—A Symptomatic Assessment Using Linear Analogue Scales
1982